Literature DB >> 18646043

Selection of best candidates for multiorgan resection among patients with T4 gastric carcinoma.

Luis F Oñate-Ocaña1, Mauricio Becker, José F Carrillo, Vincenzo Aiello-Crocifoglio, Dolores Gallardo-Rincón, Rocío Brom-Valladares, Roberto Herrera-Goepfert, Francisco Ochoa-Carrillo, Arturo Beltrán-Ortega.   

Abstract

BACKGROUND AND
OBJECTIVE: Indications for gastrectomy in T4 gastric carcinoma (GC) remain controversial. Our aim was to define prognostic factors to select those patients with best chance to benefit from multiorgan resection.
MATERIALS AND METHODS: A cohort of patients with T4 GC treated in a 19-year period. Surgical morbidity-associated factors were identified by logistic regression analysis. Prognostic factors were defined by Kaplan-Meier and Cox methods.
RESULTS: Seven hundred eighteen patients were included (gastrectomy performed in 169). Surgical morbidity and mortality were 39% and 10.7%, respectively. Surgical morbidity were associated to extent of gastrectomy, age, serum albumin, and lymphocyte count (P = 0.0001). Presence of metastasis (hazard ratio [HR], 1.68; 95% confidence interval [95% CI], 1.19-2.36), albumin <3 g/dl plus lymphocytes <1,000 cells/mm(3) (HR, 2.9; 95% CI, 1.8-4.6), presence of ascites (HR, 2.1; 95% CI, 1.06-4.2), age >or=50 (HR, 1.37; 95% CI, 1.02-1.8), and unresectable disease (HR, 2.6; 95% CI, 1.7-4.1) defined poor survival (P = 0.00001).
CONCLUSION: Performing a multiorgan resection must be balanced between chances for long-term survival and surviving a potentially fatal operation. Absence of metastases, serum albumin levels >3 g/dl, and accomplishment of R0 resection select patients with high probability of benefit from multiorgan resection. (c) 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18646043     DOI: 10.1002/jso.21118

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  11 in total

Review 1.  Impact of clinicopathological parameters on survival after multiorgan resection among patients with T4 gastric carcinoma: a systematic review and meta-analysis.

Authors:  G Zu; T Zhang; W Li; Y Sun; X Zhang
Journal:  Clin Transl Oncol       Date:  2017-01-04       Impact factor: 3.405

2.  Extended Gastrectomy for T4b Gastric Adenocarcinoma: Single-Surgeon Experience.

Authors:  Mushegh А Sahakyan; Artak Gabrielyan; Hmayak Petrosyan; Shushan Yesayan; Sevak S Shahbazyan; Arthur M Sahakyan
Journal:  J Gastrointest Cancer       Date:  2020-03

3.  Multivisceral Resection for Locally Advanced Gastric and Gastroesophageal Junction Cancers-11-Year Experience at a High-Volume North American Center.

Authors:  J C Molina; A Al-Hinai; A Gosseling-Tardif; P Bouchard; J Spicer; D Mulder; C L Mueller; L E Ferri
Journal:  J Gastrointest Surg       Date:  2018-04-16       Impact factor: 3.452

4.  Surgery for Locally Advanced GIT Cancers Has Potentially Good Postoperative Outcomes in a Tertiary Hospital.

Authors:  Anwar Tawfik Amin; Ahmed A S Salem; Abeer Ibrahim
Journal:  J Gastrointest Cancer       Date:  2020-03

5.  Is hypoalbuminemia an independent prognostic factor in patients with gastric cancer?

Authors:  Andrew B C Crumley; Robert C Stuart; Margaret McKernan; Donald C McMillan
Journal:  World J Surg       Date:  2010-10       Impact factor: 3.352

Review 6.  Multivisceral resection for gastric cancer: a systematic review.

Authors:  Savtaj S Brar; Rajini Seevaratnam; Roberta Cardoso; Lavanya Yohanathan; Calvin Law; Lucy Helyer; Natalie G Coburn
Journal:  Gastric Cancer       Date:  2011-07-23       Impact factor: 7.370

Review 7.  Gastric Cancer Invading the Pancreas: A Review of the Role of Pancreatectomy.

Authors:  Dimitrios Symeonidis; Dimitrios Zacharoulis; Labrini Kissa; Athina A Samara; Efrosyni Bompou; Konstantinos Tepetes
Journal:  In Vivo       Date:  2022 Sep-Oct       Impact factor: 2.406

8.  Extended multi-organ resection for cT4 gastric carcinoma: A retrospective analysis.

Authors:  Longbin Xiao; Mingzhe Li; Fengfeng Xu; Huishao Ye; Wenhui Wu; Shuo Long; Wenfeng Li; Yulong He
Journal:  Pak J Med Sci       Date:  2013-04       Impact factor: 1.088

Review 9.  Clinical practice guidelines for gastric cancer in Korea: an evidence-based approach.

Authors:  Jun Haeng Lee; Jae G Kim; Hye-Kyung Jung; Jung Hoon Kim; Woo Kyoung Jeong; Tae Joo Jeon; Joon Mee Kim; Young Il Kim; Keun Won Ryu; Seong-Ho Kong; Hyoung-Il Kim; Hwoon-Yong Jung; Yong Sik Kim; Dae Young Zang; Jae Yong Cho; Joon Oh Park; Do Hoon Lim; Eun Sun Jung; Hyeong Sik Ahn; Hyun Jung Kim
Journal:  J Gastric Cancer       Date:  2014-06-30       Impact factor: 3.720

10.  Surgical outcomes and prognostic factors of T4 gastric cancer patients without distant metastasis.

Authors:  Ming-zhe Li; Liang Deng; Jing-jing Wang; Long-bin Xiao; Wen-hui Wu; Shi-bin Yang; Wen-feng Li
Journal:  PLoS One       Date:  2014-09-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.